Detalles de la búsqueda
1.
In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2.
Mol Cancer Ther
; 6(12 Pt 1): 3307-13, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18089724
2.
Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides.
Cancer Res
; 64(9): 2984-7, 2004 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15126329
3.
Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824.
Cancer Res
; 64(2): 689-95, 2004 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14744786
4.
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).
J Med Chem
; 46(21): 4609-24, 2003 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-14521422
5.
Effects of drug efflux proteins and topoisomerase I mutations on the camptothecin analogue gimatecan.
Invest New Drugs
; 26(3): 205-13, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17943230
6.
Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors.
J Biol Chem
; 278(52): 52964-71, 2003 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-14534293
Resultados
1 -
6
de 6
1
Próxima >
>>